PharmX owns a sticky pharmacy transaction network, but its valuation already assumes the Sigma alliance can turn a defensive microcap gateway into a scalable high-margin marketplace.
Overview
PharmX Technologies is the dominant ANZ pharmacy EDI gateway, connecting pharmacies, wholesalers, and suppliers through mission-critical digital transaction infrastructure. After divesting legacy operations and rebranding in 2023, it now focuses on PharmX Gateway, Marketplace, portals, and analytics. Revenue comes from transaction fees, setup fees, SaaS subscriptions, commissions, and data products. Its core appeal is deeply embedded pharmacy-system integration, defensive healthcare demand, and near-universal Australian pharmacy penetration. Growth now hinges on scaling Marketplace GTV, New Zealand expansion, and the transformative Sigma/Chemist Warehouse strategic alliance.